Paola Queirolo
0000-0002-9917-6633
131 papers found
Refreshing results…
Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancer.
Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma.
Second-Line Hormonotherapy for Breast Cancer: Uselessness of First-Line Continuation
High Dose Intensity Chemotherapy without Bone Marrow Support: Role of Granulocyte-Macrophage Colony-Stimulating Factor
Impact of Irradiation of Residual Breast on Adjuvant Chemotherapy Dose Intensity:
Merkel Cell Tumor. A Review of Clinical Cases | TUMORE DI MERKEL. CONSIDERAZIONI E CASISTICA PERSONALE
Mitoxantrone and mitomycin C as second-line treatment for advanced breast cancer
Tamoxifen and Alpha Interferon in Advanced Breast Cancer
Intensive Chemotherapy with Cisplatin, Mitoxantrone, Methotrexate and Vincristine in Metastatic Breast Cancer
Continuous Venous Infusion of Vinblastine in Metastatic Breast Cancer
Chemotherapy with mitomycin-C, epidoxorubicin and vinblastine in CMF failing breast cancer patients
Missing publications? Search for publications with a matching author name.